Investors

2018 News

Keyword Search
 
2018 | 2017 | 2016 | 2015 | 2014
DateTitle 
04/19/18Coherus BioSciences Announces New Employment Inducement Grants
REDWOOD CITY, Calif., April 19, 2018 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq:CHRS), today announced that effective April 19, 2018, the compensation committee of the company’s board of directors granted 9 new employees options to purchase an aggregate of 187,000 shares of the company’s common stock with a per share exercise price of $12.05, the closing trading price on the grant date.  The stock options were granted pursuant to the Coherus BioSciences, Inc. 2016 Employment Commenc... 
Printer Friendly Version
04/02/18Coherus BioSciences Management to Present at the H.C. Wainwright Annual Global Life Sciences Conference in Monte Carlo, Monaco
REDWOOD CITY, Calif., April 02, 2018 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq:CHRS) today announced that senior management will be presenting at the H.C. Wainwright Annual Life Sciences Conference on Tuesday, April 10, 2018 at 8:10 am ET being held in Monte Carlo, Monaco. The audio portion of the presentation will be available on the investors page of the Coherus BioSciences website at http://investors.coherus.com. About Coherus BioSciences, Inc. Coherus is a leading pure-pla... 
Printer Friendly Version
03/13/18Coherus BioSciences Announces New Employment Inducement Grants
REDWOOD CITY, Calif., March 13, 2018 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq:CHRS), today announced that effective March 12, 2018, the compensation committee of the company’s board of directors granted 2 new employees options to purchase an aggregate of 37,000 shares of the company’s common stock with a per share exercise price of $12.45, the closing trading price on the grant date. The stock options were granted pursuant to the Coherus BioSciences, Inc. 2016 Employment Commencem... 
Printer Friendly Version
03/08/18Coherus BioSciences Reports Fourth Quarter and Full Year 2017 Financial Results
REDWOOD CITY, Calif., March 08, 2018 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq:CHRS), today reviewed corporate events and reported financial results for the quarter and full year ended December 31, 2017.   Fourth Quarter and Full Year 2017 Financial Results: Research and development (R&D) expenses for the fourth quarter of 2017 were $31.5 million compared to $59.0 million for the same period in 2016.  R&D expenses for the fiscal year 2017 were $162.4 million, as com... 
Printer Friendly Version
03/01/18Coherus BioSciences Management to Present at Two Investor Healthcare Conferences in March
REDWOOD CITY, Calif., March 01, 2018 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq:CHRS) today announced that senior management will present at two upcoming investor healthcare conferences. Management participation in a fireside chat at the 38th Cowen & Company Healthcare Conference on Monday, March 12th at 2:50 p.m. ET taking place in Boston, MA. Management participation in a fireside chat is scheduled at Barclays Global Healthcare Conference on Wednesday, March 14th at ... 
Printer Friendly Version
02/27/18Coherus BioSciences to Report Fourth Quarter and Full Year 2017 Financial Results on March 8th
REDWOOD CITY, Calif., Feb. 27, 2018 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq:CHRS), today announced that its fourth quarter and full year 2017 financial results will be released after market close on Thursday, March 8, 2018.  At 4:30 p.m. Eastern Time, Coherus’ management will host a conference call to discuss the financial results and provide a general business update.   After releasing fourth quarter and full year 2017 financial results, we will post them on the Coherus BioSc... 
Printer Friendly Version
01/02/18Coherus BioSciences Management to Present at The 36th Annual J.P. Morgan Healthcare Conference
REDWOOD CITY, Calif., Jan. 02, 2018 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq:CHRS), today announced that senior management will present at the 36th annual J.P. Morgan healthcare conference on Monday, January 8, 2017 at 2:00 p.m. PT being held in San Francisco. The audio portion of the presentation will be available on the investors page of the Coherus BioSciences website at http://investors.coherus.com. About Coherus BioSciences, Inc. Coherus is a leading pure-play, global bi... 
Printer Friendly Version